These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 24503888

  • 1. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P, Solé M, Unzeta M.
    Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
    Sun P, Esteban G, Inokuchi T, Marco-Contelles J, Weksler BB, Romero IA, Couraud PO, Unzeta M, Solé M.
    Br J Pharmacol; 2015 Nov; 172(22):5390-402. PubMed ID: 26362823
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
    Sun P, Hernandez-Guillamón M, Campos-Martorell M, Simats A, Montaner J, Unzeta M, Solé M.
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
    [Abstract] [Full Text] [Related]

  • 4. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
    Solé M, Unzeta M.
    Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
    [Abstract] [Full Text] [Related]

  • 5. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
    Solé M, Miñano-Molina AJ, Unzeta M.
    Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
    [Abstract] [Full Text] [Related]

  • 6. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
    Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J.
    Cerebrovasc Dis; 2012 Feb; 33(1):55-63. PubMed ID: 22133888
    [Abstract] [Full Text] [Related]

  • 7. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
    Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S.
    Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
    [Abstract] [Full Text] [Related]

  • 8. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
    Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, Salmi M.
    Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
    [Abstract] [Full Text] [Related]

  • 9. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S.
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [Abstract] [Full Text] [Related]

  • 10. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
    Hernandez-Guillamon M, Garcia-Bonilla L, Solé M, Sosti V, Parés M, Campos M, Ortega-Aznar A, Domínguez C, Rubiera M, Ribó M, Quintana M, Molina CA, Alvarez-Sabín J, Rosell A, Unzeta M, Montaner J.
    Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
    [Abstract] [Full Text] [Related]

  • 11. Vascular adhesion protein-1 in human ischaemic stroke.
    Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S.
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
    [Abstract] [Full Text] [Related]

  • 12. Origins of serum semicarbazide-sensitive amine oxidase.
    Stolen CM, Yegutkin GG, Kurkijärvi R, Bono P, Alitalo K, Jalkanen S.
    Circ Res; 2004 Jul 09; 95(1):50-7. PubMed ID: 15178639
    [Abstract] [Full Text] [Related]

  • 13. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
    Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D.
    Biochim Biophys Acta; 2003 Apr 11; 1647(1-2):193-9. PubMed ID: 12686132
    [Abstract] [Full Text] [Related]

  • 14. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M, Esteban-Lopez M, Taltavull B, Fábregas C, Fadó R, Casals N, Rodríguez-Álvarez J, Miñano-Molina AJ, Unzeta M.
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep 01; 1865(9):2189-2202. PubMed ID: 31047972
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL, Chuang LM, Li HY.
    Transl Res; 2018 Jul 01; 197():12-31. PubMed ID: 29653075
    [Abstract] [Full Text] [Related]

  • 16. Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia.
    Xu HL, Salter-Cid L, Linnik MD, Wang EY, Paisansathan C, Pelligrino DA.
    J Pharmacol Exp Ther; 2006 Apr 01; 317(1):19-29. PubMed ID: 16339390
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM, Wang E, O'Rourke AM, Miller A, Gao H, Huang L, Garcia A, Linnik MD.
    J Pharmacol Exp Ther; 2005 Nov 01; 315(2):553-62. PubMed ID: 16081681
    [Abstract] [Full Text] [Related]

  • 18. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
    Abella A, García-Vicente S, Viguerie N, Ros-Baró A, Camps M, Palacín M, Zorzano A, Marti L.
    Diabetologia; 2004 Mar 01; 47(3):429-438. PubMed ID: 14968297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
    Jargaud V, Bour S, Tercé F, Collet X, Valet P, Bouloumié A, Guillemot JC, Mauriège P, Jalkanen S, Stolen C, Salmi M, Smith DJ, Carpéné C.
    J Physiol Biochem; 2021 Feb 01; 77(1):141-154. PubMed ID: 32712883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.